Is the worm in the fruit?
While the European Medicines Agency confirmed a few days ago a "rare" risk of thrombosis after the administration of the AstraZeneca vaccine, the story of this serum, on which France has relied a large part of its campaign of vaccination, seems increasingly upset.
READ ALSO>
Covid: Pfizer which is accelerating, AstraZeneca which is stammering ... where is the vaccination campaign
Thus, according to France Bleu, hundreds of appointments were canceled in the vaccination centers of Calais, Gravelines and Boulogne-sur-Mer on Saturday and Sunday and nearly 1,200 doses of AstraZeneca thus remained without finding a taker.
In detail, Saturday in Calais, of the 750 doses of the Anglo-Swedish vaccine that were to be administered to eligible patients, only 200 were.
The remainder being returned to the fridges and will be used up in the next few days.
Same scenario in Gravelines, with nearly 800 doses planned, but where only 130 people finally showed up.
Or more than 600 orphan doses ... And in Boulogne-sur-Mer this Sunday, this time more than 160 doses have not found takers, according to the Voix du Nord.
"All vaccines are effective against the coronavirus"
This mistrust, while this phenomenon of appointment cancellation is not at all observed when it is a vaccine other than AstraZeneca that is offered, is therefore explained by recent statements around very limited cases of thromboses around the world but which frighten.
As of Saturday morning, out of 18 million doses administered throughout the UK vaccine campaign, the UK only declared seven fatal cases.
In all, 34 cases of thrombosis were identified.
Visiting the Marcq-en-Barœul (North) vaccinodrome on Sunday afternoon to reassure the population, the Minister of the Interior Gerald Darmanin once again urged the French to be vaccinated.
“All vaccines are effective against the coronavirus,” he said.